BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang JE, Choi MS. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. Int J Mol Sci 2020;21:E8960. [PMID: 33255783 DOI: 10.3390/ijms21238960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Monte-serrano J, Villagrasa-boli P, Cruañes-monferrer J, Arbués-espinosa P, Martínez-cisneros S, García-gil MF. Metformina en el tratamiento de enfermedades dermatológicas: una revisión narrativa. Atención Primaria 2022;54:102354. [DOI: 10.1016/j.aprim.2022.102354] [Reference Citation Analysis]
2 Jain H, Bhat AR, Dalvi H, Godugu C, Singh SB, Srivastava S. Repurposing approved therapeutics for new indication: Addressing unmet needs in psoriasis treatment. Curr Res Pharmacol Drug Discov 2021;2:100041. [PMID: 34909670 DOI: 10.1016/j.crphar.2021.100041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Choi MS, Chae YJ, Choi JW, Chang JE. Potential Therapeutic Approaches through Modulating the Autophagy Process for Skin Barrier Dysfunction. Int J Mol Sci 2021;22:7869. [PMID: 34360634 DOI: 10.3390/ijms22157869] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Stanescu AMA, Simionescu AA, Florea M, Diaconu CC. Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review. J Pers Med 2021;11:251. [PMID: 33808460 DOI: 10.3390/jpm11040251] [Reference Citation Analysis]
5 Al Za'abi M, Ali BH, Al Suleimani Y, Adham SA, Ali H, Manoj P, Ashique M, Nemmar A. The Effect of Metformin in Diabetic and Non-Diabetic Rats with Experimentally-Induced Chronic Kidney Disease. Biomolecules 2021;11:814. [PMID: 34070807 DOI: 10.3390/biom11060814] [Reference Citation Analysis]